Sort
39,280 grants matching “leukemia”
Translating genomic discoveries to improved outcomes for high risk acute leukemia
$1,044,690Charles G. Mullighan · St. Jude Children'S Research Hospital · R35 · FY2019 · CA
ETS GENES AND TRANSFORMATION AND DIFFERENTIATION
$1,044,628Medical University Of South Carolina · P01 · FY2001 · CA
Cancer and Leukemia Group B-Leukemia Correlative Science
$1,044,208Ohio State University · U10 · FY2005 · CA
Targeting Tumor Suppressive Pathways for Cancer Therapy
$1,044,000Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · R35 · FY2016 · CA
Targeting Tumor Suppressive Pathways for Cancer Therapy
$1,044,000Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · R35 · FY2018 · CA
Targeting Tumor Suppressive Pathways for Cancer Therapy
$1,044,000Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · R35 · FY2017 · CA
Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency
$1,043,986Dennis Hickstein · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
AC-225 Imaging R01 Transfer
$1,043,907Javier Caravaca · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2024 · EB
Molecular Pharmacology Lab
$1,043,878Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2023 · CA
PATHOGENESIS OF PERSISTENT VIRAL INJURY TO THE CNS
$1,043,808University Of Pennsylvania · P01 · FY2000 · NS
CANCER AND LEUKEMIA GROUP B CCOP RESEARCH BASE
$1,043,494University Of Chicago · U10 · FY2000 · CA
Delaware/Christiana Care CCOP
$1,042,698Stephen S. Grubbs · Christiana Care Health Services, Inc. · U10 · FY2008 · CA
Growth-Differentiation Factors in Organogenesis
$1,042,630Alan Perantoni · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Search for the Structural Basis of Biomacromolecular Function and Activity
$1,042,358Yun Xing M Wang · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Mechanisms of regulation by RNA in acute myeloid leukemia
$1,042,185Daniel G Tenen · Beth Israel Deaconess Medical Center · R35 · FY2016 · CA
Mechanisms of regulation by RNA in acute myeloid leukemia
$1,042,185Daniel G Tenen · Beth Israel Deaconess Medical Center · R35 · FY2018 · CA
Mechanisms of regulation by RNA in acute myeloid leukemia
$1,042,185Daniel G Tenen · Beth Israel Deaconess Medical Center · R35 · FY2020 · CA
Mechanisms of regulation by RNA in acute myeloid leukemia
$1,042,185Daniel G Tenen · Beth Israel Deaconess Medical Center · R35 · FY2021 · CA
Mechanisms of regulation by RNA in acute myeloid leukemia
$1,042,185Daniel G Tenen · Beth Israel Deaconess Medical Center · R35 · FY2015 · CA
Impact of Celecoxib and Inflammation on Survival in Stage III Colon Cancer
$1,041,509Charles S Fuchs · Yale University · R01 · FY2017 · CA
GrowthDifferentiation Factors in Organogenesis
$1,041,001Alan Perantoni · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.
$1,040,761David A Scheinberg · Sloan-Kettering Inst Can Research · R35 · FY2022 · CA
Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.
$1,040,761David A Scheinberg · Sloan-Kettering Inst Can Research · R35 · FY2023 · CA
Towards targeting the lymphoma microenvironment
$1,040,760Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R35 · FY2022 · CA
Novel Targets for Vaccine Therapy
$1,039,362Claudia Palena · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA